Die meistzitierten Artikel
|
Rang |
Autoren |
Paper |
Zitierungen |
1. | Cohen SB, ..., Burmester GR, ..., Totoritis MC. | Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. ARTHRITIS RHEUM 2006, 54(9):2793-806 | 394 |
2. | Diarra D, ..., Polzer K, Zwerina J, ..., Korb A, Smolen J, Hoffmann M, Scheinecker C, ..., Schett G. | Dickkopf-1 is a master regulator of joint remodeling. NAT MED 2007, 13(2):156-63 | 218 |
3. | van der Heijde D, ..., Sieper J, ..., Braun J. | Efficacy and safety of infliximab in patients with ankylosing spondylitis. ARTHRITIS RHEUM 2005, 52(2):582-91 | 211 |
4. | Maini RN, ..., Smolen J, ..., Kishimoto T. | Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. ARTHRITIS RHEUM 2006, 54(9):2817-29 | 210 |
5. | Smolen JS, ..., Rubbert-Roth A, ..., Alten R. | Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. LANCET 2008, 371(9617):987-97 | 207 |
6. | Antoni CE, ..., Burmester GR, Schneider U, ..., Manger B, Wassenberg S, Weier R, ..., Kalden JR, Smolen J. | Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis. ARTHRITIS RHEUM 2005, 52(4):1227-36 | 206 |
7. | Listing J, Strangfeld A, Kary S, Rau R, ..., Stoyanova-Scholz M, Gromnica-Ihle E, Antoni C, Herzer P, ..., Schneider M, Zink A. | Infections in patients with rheumatoid arthritis treated with biologic agents. ARTHRITIS RHEUM 2005, 52(11):3403-12 | 186 |
8. | Wakefield RJ, ..., Backhaus M, ..., Schmidt WA, ..., Manger B, ..., Kainberger F, Klauser A, ..., Machold KP, Conaghan PG. | Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J RHEUMATOL 2005, 32(12):2485-7 | 155 |
9. | de Groot K, ..., Gross WL, ..., Jayne DR. | Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. ARTHRITIS RHEUM 2005, 52(8):2461-9 | 155 |
10. | van der Heijde D, ..., Sieper J, ..., Braun J, ..., Kupper H, Davis JC. | Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial. ARTHRITIS RHEUM 2006, 54(7):2136-46 | 151 |